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hypothesis-driven research. I still 
relish the time when, as a naïve 
Ph.D. student, I was unaware of 
fashion and the need to please top 
journals. This allowed me to follow 
compulsively one aim, which 
I had convinced myself to be 
worthwhile. Other pieces of advice 
are to keep career plans flexible 
enough to allow collaborators to 
influence one’s research direction 
and to synergise with local 
expertise. 
Is there any quality that you wish 
you had more of?  
Self-confidence is an important 
trait when naïveté has worn off. 
Once a decision is made to follow 
up on a project, one must persist 
long enough to see its potential 
(or unforeseen limitation). On more 
than one occasion, I failed to 
follow valid avenues of research 
because I could not overcome 
naysayers’ comments or because 
I did not trust my own judgement. 
One cannot wait for the approval 
of most peers. Of course, it is 
important to know when to give up 
a doomed project. In this respect, 
having close friends, colleagues 
or mentors who are constructively 
critical is invaluable. 
What is your favourite 
conference? The EMBO 
Workshop on the Molecular 
and Developmental Biology 
of Drosophila, held in Crete 
every two years. This meeting 
is elitist and egalitarian at the 
same time. Only 100 applicants 
can attend — they are selected 
from a pool of applicants by 
a rotating committee — but 
once there, everyone speaks 
for just 12 minutes. Talks 
often report emerging areas of 
research on a wide diversity 
of subjects, including cell 
biology, developmental biology, 
neurobiology and innate immunity. 
The atmosphere is both relaxed 
(with plenty of wine and sea views) 
and pressured (many sharp minds 
attend). Of course one cannot live 
off Drosophila and wine alone, and 
I value highly my colleagues who 
work with other model organisms.
Do you have a scientific hero? 
My scientific heroes are my three 
mentors, John Gerhart, George 
Oster and Pat O’Farrell. They are 
at the same time creative and 
intellectually rigorous. Also they 
really care about their collaborators 
as human beings and as scientists 
with professional aspirations.
Do you have any qualms about 
the fact that the pursuit you enjoy 
is funded by public money? I do 
at times, but such anxieties are 
easily allayed when I am reminded 
that basic science provides the 
essential foundation on which 
improvements in public health are 
based. There is a current push to 
increase translational research at 
the expense of basic research. 
It would be more effective to 
my mind to make sure that 
career structures allow the free 
movement of people from one to 
the other.
Name one big challenge 
for developmental biology? 
Developmental biology has 
uncovered most of the regulatory 
pathways that control cell-fate 
decisions. How these pathways 
control cell behaviour and hence 
morphogenesis remains largely 
unknown. Many genes that are 
regulated by these pathways are 
being identified. The challenge is 
to build an integrated picture of 
how these effector genes drive 
specific morphogenetic events at 
the cellular and tissue level.
Is mathematical modelling in 
developmental biology a tool or 
a fad? As biology is becoming 
more quantitative, mathematical 
modelling features increasingly in 
biology papers. This trend extends 
to phenomena that are still poorly 
quantified, for example morphogen 
transport. Models are useful 
because they tell us the realm 
of what is physically possible 
but they are also limited when 
validation is hampered by poor 
quantitative knowledge of all the 
relevant parameters — receptor 
levels, binding constants, and so 
on. Measuring these parameters 
in vivo is an essential prerequisite 
even though it is not viewed as 
very glamorous.
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First discovered… Endosomal 
sorting complex required 
for transport (ESCRT)-I was 
discovered and characterized 
biochemically in 2001, and two 
functionally related complexes, 
ESCRT-II and -III, were described 
the following year. However, 
almost all of the individual 
subunits had been discovered 
earlier through yeast genetic 
screens for vacuolar protein 
sorting (vps) mutants. Among the 
multiple vps mutants identified 
to date, those lacking functional 
ESCRT subunits belong to the 
so- called ‘class E’ group, which 
is characterized by a large 
multilamellar endosome, the ‘class 
E compartment’. 
What do they look like? ESCRT- I 
consists of equimolar amounts 
of the subunits Vps23, Vps28 
and Vps37. The carboxyl 
terminus of Vps23 together with 
the amino-terminal half of Vps28 
and carboxy-terminal end of 
Vps37 build the core of ESCRT- I, 
which resembles a fan. The 
ubiquitin-binding amino terminus 
of Vps23 protrudes from the 
core via a long arm. ESCRT-II is 
Y-shaped and consists of one 
subunit of Vps22, two of Vps25 
and one of Vps36. ESCRT-III is 
made of two subcomplexes, 
one containing Vps2 and Vps24 
and the other containing Vps32 
and Vps20. All the ESCRT-III 
members are small coiled-
coil proteins that have a basic 
amino terminus and an acidic 
carboxyl terminus and assemble 
as higher-order multimers on 
membranes.
Can we live without them? 
Certainly not. The ESCRTs are 
conserved from yeast to man and 
have essential functions in higher 
eukaryotes as evidenced by the 
embryonic lethality of mice that 
lack ESCRT subunits. 
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do they get there? The ESCRTs 
are recruited from the cytosol 
onto the limiting membranes of 
endosomes. ESCRT-I is recruited 
to endosome membranes through 
interaction of its Vps23 subunit 
with the phosphatidylinositol 
3-phosphate (PtdIns(3)P)-binding 
endosomal protein Vps27 (known 
as Hrs in mammals). ESCRT-II  
is presumably recruited via 
interactions between the Vps36 
subunit and the Vps28 subunit of 
ESCRT-I. ESCRT-III is probably 
recruited to endosomes through 
an interaction between its Vps20 
subunit and Vps25 in ESCRT-II. The membrane recruitment of 
ESCRTs may also be stimulated 
by cargo binding and by binding 
to the phosphoinositides 
PtdIns(3)P (via Vps36 in ESCRT-II) 
and PtdIns(3,5)P2 (via Vps24 in 
ESCRT-III). 
What do they do? The ESCRTs are 
best known for their essential role 
in sorting ubiquitinated membrane 
proteins from early endosomes 
to lysosomes via multivesicular 
endosomes (MVEs; Figure 1), even 
though some of the subunits in 
higher organisms were originally 
discovered for their involvement 
in other cellular functions, such U
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Figure 1. Role of ESCRTs in sorting of ubiquitinated membrane proteins from endo-
somes to lysosomes, showing ESCRT-mediated downregulation of a growth factor 
 receptor as an example. 
Ligand binding causes covalent attachment of ubiquitin (U) to the receptor, which 
 becomes internalized by endocytosis. In the endosome membrane, the ubiquitin 
 moiety functions as recognition tag for Vps27 (indicated in pink), which accumulates 
cargo destined for lysosomes in specific microdomains. Vps27 recruits ESCRT-I 
(blue) which acquires the ubiquitinated cargo and delivers it to ESCRT-II (orange). 
Finally, ESCRT-III (green) is recruited by ESCRT-II and mediates formation of endosomal 
invaginations and intraluminal vesicles (ILVs) into which cargo is sorted. Deubiquiti-
nation of cargo and disassembly of the ESCRT machinery (catalyzed by the ATPase 
Vps4, indicated in purple) are required prior to ILV formation. The early endosome 
develops into a multivesicular endosome (MVE) containing numerous ILVs with cargo 
that are then degraded upon fusion with lysosomes.as regulation of transcription, 
cell polarity and cell proliferation. 
According to the working model 
describing endosomal sorting, 
cargo is first recognized by Vps27 
(Hrs) and then transferred to 
the Vps23 subunit of ESCRT-I. 
Subsequently the ubiquitinated 
cargo is transferred to the Vps36 
subunit of ESCRT-II for sorting into 
endosomal invaginations formed 
through assembly/disassembly 
of ESCRT-III polymers. The 
mechanism underlying transfer 
of ubiquitinated cargo from one 
ESCRT to another is presently 
unknown, but deubiquitination 
occurs prior to sequestration of 
cargo into intraluminal vesicles 
within the endosome.
How are they regulated? So far 
we know little about the regulation 
of the assembly of ESCRTs. 
However, there is good evidence 
that the ATPase Vps4 mediates 
disassembly of the ESCRT-III 
complex. 
Are they involved in diseases? 
ESCRTs are involved in the release 
of enveloped viruses, such as 
HIV, apparently via hijacking of 
the ESCRT machinery by viral 
Gag proteins during viral budding. 
ESCRT subunits function as 
tumour suppressors in Drosophila, 
possibly by guiding certain 
signaling receptors to lysosomes 
for their degradation and 
silencing. Tsg101, the mammalian 
homologue of the ESCRT-I subunit 
Vps23, was first discovered as a 
putative tumour suppressor gene. 
However, conditional knockout of 
Tsg101 does not induce tumours in 
mice, and the tumour suppressor 
function of Tsg101 in mammals 
thus remains controversial. 
Where can I find out more?
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